ubenimex (DFP-14323)

News alerts, weekly reports and conference planners

Company:

Delta-Fly Pharma

Drug class:

CD13 inhibitor

‹

›

EGFR exon 19 deletion	Non Small Cell Lung Cancer	EGFR exon 19 deletion	Non Small Cell Lung Cancer	afatinib + DFP-14323 Sensitive: C3 – Early Trials afatinib + DFP-14323 Sensitive : C3	afatinib + DFP-14323 Sensitive: C3 – Early Trials afatinib + DFP-14323 Sensitive : C3
EGFR L858R	Non Small Cell Lung Cancer	EGFR L858R	Non Small Cell Lung Cancer	afatinib + DFP-14323 Sensitive: C3 – Early Trials afatinib + DFP-14323 Sensitive : C3	afatinib + DFP-14323 Sensitive: C3 – Early Trials afatinib + DFP-14323 Sensitive : C3

Associations
(2)